Mindray to Report Second Quarter 2008 Financial Results on September 3, 2008
08 Agosto 2008 - 2:30PM
PR Newswire (US)
SHENZHEN, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- Mindray
Medical International Limited (NYSE:MR), a leading developer,
manufacturer and marketer of medical devices worldwide today
announced that it will report its financial results for the second
quarter ended June 30, 2008, after the U.S. market closes on
September 3, 2008. Mindray's management will hold an earnings
conference call at 8:00 a.m. on September 4, 2008 U.S. Eastern Time
(8:00 p.m. on September 4, 2008 Beijing/Hong Kong Time) to discuss
results with investors. As announced in May 2008, Mindray changed
its reporting currency to the U.S. Dollar (USD) from Chinese
Renminbi effective April 1, 2008. Accordingly, Mindray will present
historical financial results retranslated into USD in order to
allow same currency comparisons to future financial results, to be
released in USD. Mindray will release these historical financial
results presented in USD on August 26, 2008. This retranslation
does not reflect any change in the underlying historical results
and reflects only exchange rate recalculation into USD based on the
accounting guidance for retranslation into a new reporting
currency. Dial-in details for the earnings conference call are as
follows: Hong Kong: +852-3002-1672 U.S. Toll Free: +1-800-638-5439
International: +1-617-614-3945 Passcode for all regions: Mindray A
replay of the conference call may be accessed by phone at the
following numbers until September 15, 2008. U.S. Toll Free:
+1-888-286-8010 International: +1-617-801-6888 Passcode: 42471484
Additionally, a live and archived webcast of this conference call
will be available on the Investor Relations section of Mindray's
website at http://www.mindray.com/ . About Mindray Mindray is a
leading developer, manufacturer and marketer of medical devices
worldwide. Established in 1991, Mindray offers a broad range of
products across three primary business segments: patient monitoring
& life support products, in-vitro diagnostic products and
medical imaging systems. Mindray is globally headquartered in
Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey.
Mindray also has another 12 international sales and service offices
in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow,
Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver. For more
information, please visit http://www.mindray.com/ . Safe Harbor
Statement This announcement contains forward-looking statements.
These statements are made under the "safe harbor" provisions of the
U.S. Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," "confident" and similar statements.
Statements that are not historical facts, including statements
about Mindray's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and
uncertainties. Information regarding these risks and uncertainties
is included in our public filings with the Securities and Exchange
Commission. All information provided in this press release is as of
August 4, 2008, and Mindray undertakes no duty to update such
information, except as required under applicable law. For investor
and media inquiries, please contact: In the U.S: Evan Smith, FD
Tel: +1-212-850-5606 Email: John Capodanno, FD Tel: +1-212-850-5705
Email: In China: May Li Mindray Medical International Limited Tel:
+86-755-2658-2518 Email: DATASOURCE: Mindray Medical International
Limited CONTACT: In the U.S: Evan Smith, FD, +1-212-850-5606, or ;
Or John Capodanno of FD, +1-212-850-5705, or ; Or In China: May Li
of Mindray Medical International Limited, +86-755-2658-2518, or Web
site: http://www.mindray.com/
Copyright
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024